drugIndia
Cart
Glimixia-M1 Tablet PR

Glimixia-M1 Tablet PR

Glimepiride (1mg) + Metformin (500mg)

Wings Biotech Ltd
Anti-Vomiting
59.2574.0620% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 54%
Best Alternative100% Match

Glyzee M1 PR Tablet

Zeelab Pharmacy Pvt Ltd

Glimepiride 1mg
Glyzee M1 PR Tablet

Pack Size

1 units

Price

27.0020% off
Glyzee M1 PR Tablet is 100% same as Glimixia-M1 Tablet PR
Better ValueSame QualitySame Effectiveness

Save ₹32

that's 54% off!

composition
  1. Glimepiride 1mg
  2. Metformin 500mg
Buy Now
59.2520% OFF
74.06

About This Medicine

Product description & overview

Glimixia-M1 Tablet PR

Glimixia-M1 Tablet PR combines the effective doses of Glimepiride (1mg) and Metformin (500mg) to manage blood sugar levels in adults with type 2 diabetes. This once-daily combination tablet provides convenient, stable control.

How it Works:
* Glimepiride: This sulfonylurea medication helps the body release insulin more effectively from the pancreas, increasing glucose utilization and lowering blood sugar levels.
* Metformin: A first-line oral medication, metformin works by reducing glucose production in the liver and improving insulin sensitivity, ultimately managing blood sugar levels.

Benefits: Glimixia-M1 Tablet PR offers:
* Combined effect for effective glycemic control
* Once daily administration for ease of use
* Suitable for patients with type 2 diabetes who require a convenient and reliable treatment option.

Consult your doctor or pharmacist before starting any new medication. This product is not suitable for individuals with type 1 diabetes, pregnant or breastfeeding women, or those with specific medical conditions.

Note: This description provides general information. It should not be considered a substitute for professional advice from healthcare providers.

Active composition

Glimepiride 1 mg

+1 more active ingredient

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Metformin500 mg

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimixia-M1 Tablet PR.

High Risk

Pregnancy

Glimixia-M1 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimixia-M1 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glimixia-M1 Tablet PR may be needed. Please consult your doctor. Glimixia-M1 Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimixia-M1 Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Consult Doctor

Kidney

Glimixia-M1 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glimixia-M1 Tablet PR may be needed. Please consult your doctor. Use of Glimixia-M1 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glimixia-M1 Tablet PR

Products matching your search